Elite Pharmaceuticals Inc (ELTP)

[mrwrn2010]

No IR ADT drugs have ever been approved. When they (Elite) do get theirs approved, there will still likely be little to no competition in that particular segment of the market. Saying they are outmatched in an industry is disingenuous when you look at the facts - no other large pharma is involved in the IR ADT space that SequestOx will be in. Even the mighty Purdue has failed at getting their IR ADT drug approved.

On the ER ADT side, yes, that will be a good bit more competitive against other approved and established drugs.

Hope that helps.